Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
3
×
clinical trials
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
3
×
life sciences
national
national blog main
national top stories
3
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
forty seven
ipo
nivolumab
rna
abbvie
aimmune therapeutics
akouos
allergan
alnylam pharmaceuticals
What
ipo
3
×
bio
companies
life
roundup
science
sciences
week
acquisitions
announced
arena’s
biotechs
bounty
ceo
cig
club
collabs
comeback
continued
corner
covid
crop
daniel
deal
deals
delivered
exceeded
expressing
firms
gilead
gilead’s
group
haul
help
introduce
joined
latest
little
medicines
met
Language
unset
Current search:
fda
×
ipo
×
" national top stories "
×
" indiana top stories "
×
" cancer immunotherapy "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M